Clinical Study Double-Blind Randomized Placebo Controlled
Total Page:16
File Type:pdf, Size:1020Kb
Hindawi Cholesterol Volume 2018, Article ID 4857473, 9 pages https://doi.org/10.1155/2018/4857473 Clinical Study Double-Blind Randomized Placebo Controlled Trial Demonstrating Serum Cholesterol Lowering Efficacy of a Smoothie Drink with Added Plant Stanol Esters in an Indonesian Population Lanny Lestiani,1 Dian Novita Chandra ,1 Kirsi Laitinen ,2 Fransisca Diah Ambarwati,3 Päivi Kuusisto ,4 and Widjaja Lukito 5 1 Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia 2Institute of Biomedicine, University of Turku, 20014 Turku, Finland 3Sanghiang Perkasa-Kalbe Nutritionals, Jakarta, Indonesia 4Raisio Group, P.O. Box 101, 21201 Raisio, Finland 5Human Nutrition Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia Correspondence should be addressed to Paivi¨ Kuusisto; [email protected] Received 25 August 2017; Accepted 1 January 2018; Published 4 February 2018 Academic Editor: Katherine Gottschall-Pass Copyright © 2018 Lanny Lestiani et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Indonesians have a high intake of saturated fats, a key contributing dietary factor to elevated blood cholesterol concentrations. We investigated the cholesterol lowering efcacy of a smoothie drink with 2 grams of plant stanols as esters to lower serum total and LDL-cholesterol concentrations in hypercholesterolemic Indonesian adults. Te double-blind randomized placebo controlled parallel design study involved 99 subjects. Fify subjects received control drink and dietary advice, and 49 subjects received intervention drink (Nutrive Benecol5) and dietary advice. Baseline, midline (week 2), and endline (week 4) assessments were undertaken for clinical, anthropometric, and biochemical variables. Compared to control, the smoothie drink with plant stanols reduced serum LDL-cholesterol concentration by 7.6% (� < 0.05) and 9.0% (� < 0.05)intwoandfourweeks,respectively.Serum total cholesterol was reduced by 5.7% (� < 0.05 compared to control) in two weeks, and no further reduction was detected afer four weeks (5.6%). Compared to baseline habitual diet, LDL-cholesterol was reduced by 9.3% (� < 0.05) and 9.8% (� < 0.05)inthe plant stanol ester group in two and four weeks, respectively. We conclude that consumption of smoothie drink with added plant stanol esters efectively reduces serum total and LDL-cholesterol of hypercholesterolemic Indonesian subjects already in two weeks. TrialisregisteredasNCT02316808. 1. Introduction indicates that the cardiovascular diseases are already the leading cause of death in Indonesia, accounting for 37% Similarly to other countries in Asia-Pacifc region, the of all mortality [3]. In Indonesia the major risk factors for prevalence of cardiovascular disease in Indonesia is rising cardiovascular diseases are elevated blood pressure, elevated [1]. Data from the Indonesian National Household Survey blood cholesterol, and cigarette smoking [1]. Prevalence of showed that the cause of death from noncommunicable elevated (>200 mg/dl) total cholesterol is estimated to be 40% diseases increased from 25 percent in 1980 to 49 percent in women and 30% in men [1]. Ideally, strategies to reduce in 2001 [2]. In a similar pattern, the proportion of deaths the incidence of cardiovascular diseases should be targeted arising from cardiovascular diseases in 2001 (26%) tripled at primary prevention, especially through dietary habits [4]. since 1986 (9%) [2] and has continued to rise. Recent data Furthermore, healthy dietary practices contribute to reduced 2 Cholesterol Table 1: Schedule of assessments. Week −2 (screening) 0 2 4 Informed consent X Medical history X Physical examination XX X Anthropometric measurement XX X Biochemical tests XXXX Healthy diet advice X Adverse events XX Concurrent medications XX Monitoring through phone calls XX Compliance assessment XX morbidity and mortality rates also for secondary prevention to adhere to the study conditions. Pregnant women, obese 2 [5]. (BMI > 30 kg/m ), diabetic subjects or subjects with random Initial maneuvers to manage dyslipidemia should be plasma glucose concentration >200 mg/dL, subjects with throughadietaryapproachwithaparticularfocuson hyperthyroidism, a history of metabolic, endocrine and kid- improving the quality of ingested dietary fat [6]. Terapeutic ney disorders, and acute or chronic severe diseases possibly lifestyle changes are however ofen considered burdensome interfering with the evaluation of the outcome of the clinical and call for easily applicable means for dietary modifcation trial (such as AIDS, tumor diseases, malignant hypertension, [7]. Te development of functional foods, with specifc func- and cardiac insufciency according to NYHA III-IV), and tional properties additive to normal nutritional value, should subjects who were taking lipid lowering medication or other be pursued. Plant stanols incorporated in foods as esters medications likely to afect lipid metabolism were excluded represent an important functional food substance with lipid from the study. lowering properties. Vigorous scientifc evidence pertaining Prior to commencement of the screening, the study was the total and LDL-cholesterol lowering properties of plant explained to each subject and a written informed consent stanol esters has led to their adoption as a target for lipid was signed. Te study protocol was approved by the Medical lowering modalities by several international bodies [8]. Ethics Committee of the Faculty of Medicine, Universitas While many studies demonstrating the lipid lowering Indonesia, Jakarta, Indonesia. Te study conforms to the efects of plant stanol esters have been carried out on provisions of the Declaration of Helsinki in 1995, as revised Caucasian subjects [9], the evidence is scarce for non- in Edinburgh in 2000. Caucasians, including Asians, and needs to be confrmed A total of 156 subjects indicated their interest to par- due to potential cultural diferences—through diferent food ticipateinthestudy.Teywereinvitedtovisittheclinic habits and practices. Te mainstream Indonesians are known for screening of the eligibility. Figure 1 depicts the study as a population with a high intake of saturated fats [10, 11], the fow. 99 subjects who met the entry criteria at screening key contributory dietary component to high total cholesterol were randomly allocated in a double-blind manner to receive and LDL-cholesterol concentrations [7, 12]. Terefore, the either control (�=50)orplantstanolester(�=49) present study aimed to demonstrate the lipid lowering efects smoothie drinks. Simple randomization was used. Tree of plant stanol esters in an Indonesian population. subjects in the control group and fve subjects in the plant stanol ester group discontinued the study. Of the subjects 2. Materials and Methods whocompletedtheintervention,twointhecontrolgroupand one in the plant stanol ester group were excluded from the 2.1. Study Design and Subjects. Tis double-blind random- statistical analyses because of triglyceride levels >400 mg/dl ized controlled parallel design study was conducted at the at one or several sampling points, making LDL-cholesterol Department of Nutrition, Faculty of Medicine, University determination by Friedewald formula inappropriate [13]. An of Indonesia. Te study involved 99 subjects (44 male and overall of 88 subjects were included in the statistical analyses. 55 female), aged 24–68 (mean age 47) years, who met the Te study included four visits to the study clinic, includ- following entry criteria: total cholesterol concentration ≥ ingascreeningvisit.Table1summarizestheoverallproce- 200 mg/dL and <300 mg/dL and/or LDL-C concentration ≥ dures undertaken on each subject at screening (week −2), 130 mg/dL and <240 mg/dL, willingness to consume control baseline (week 0), midline (week 2), and endline (week 4) or plant stanol ester smoothie drinks two bottles per day phases.Clinicvisitswithinanintervaloftwodaysbeforeor immediately afer a meal for four weeks, being reachable afer the appointment date were tolerated. by phone, and willingness to declare written informed consent, and agreement in accordance with data protective 2.2. Clinical Examination. General physical examination was stipulations and readiness to participate in the trial and undertaken to obtain information on vital signs and to Cholesterol 3 156 subjects agreed to give informed consent and visited the clinic 2 subjects were unable to come to the clinic 154 subjects were assessed for eligibility at screening 53 subjects were not eligible due to 2 (i) "-) > 30 EA/G (ii) Diabetes (iii) Liver dysfunction (iv) Hyperthyroidism (v) 4# < 200 GA/>,, LDL-C < 130 GA/>, (vi) 4# > 300 GA/>, 2 subjects were eligible, but not able to come for further visit 99 subjects were randomly assigned 50 subjects were allocated to 49 subjects were allocated to receive control drink receive Nutrive BenecoF drink (control group) (Benecol group) 6 subjects were discontinued 5 subjects were discontinued prematurely from the study due to prematurely from the study due to (i) Entry violation (i) Adverse event/intercurrent illnesses (ii) Adverse event/intercurrent illnesses (ii) Did not cooperate (iii) Other protocol violations (iii) Failure to return for follow-up (iv) 4' > 400 GA/>F (iv) Other protocol violations